Presentation Information
[O-28-1]Synaptic proteomics reveals key proteins of neuromuscular junction pathology in FUS-ALS
Ryuhei Harada1, Naoki Suzuki1,2, Atsushi Hatano3, Naoko Nakamura1, Akiyuki Ohno1, Saki Saitoh1, Tetsuya Akiyama1,4, Yasuaki Watanabe1,5, Shio Mitsuzawa1, Tomomi Shijo1, Kensuke Ikeda1, Hiroya Ono1,6, Ayumi Nishiyama1, Rumiko Izumi1, Yukino Funayama1,5, Hitoshi Warita1, Satoru Morimoto7,8,9, Hideyuki Okano7,8,9, Masaki Matsumoto3, Masashi Aoki1 (1.Department of Neurology, Tohoku University Graduate School of Medicine, Japan, 2.Department of Rehabilitation Medicine, Tohoku University Graduate School of Medicine, Japan, 3.Department of Omics and Systems Biology, Graduate School of Medical and Dental Sciences, Niigata University, Japan, 4.Department of Genetics, Stanford University School of Medicine, USA, 5.Division of Cell Proliferation, ART, Graduate School of Medicine, Tohoku University, Japan, 6.Department of Neuromuscular Research, National Institute of Neuroscience and Department of Genome Medicine Development, Medical Genome Center, National Center of Neurology and Psychiatry (NCNP), Japan, 7.Keio University Regenerative Medicine Research Center (KRM), Japan, 8.Keio University iPS Cell Research Center for Intractable Neurological Diseases (KiND), Japan, 9.Division of Neurodegenerative Disease Research, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Japan)